Pharma Journalist 8769 posts 0 comments

GSK plc has announced that China’s drug regulator has accepted its new drug application for linerixibat to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC),…
Read More...

Novo Nordisk and Vivtex Corporation have announced a strategic partnership to develop next-generation oral biologic medicines targeting obesity, diabetes and related metabolic…
Read More...

IQVIA Holdings Inc. has entered into an agreement to acquire certain drug discovery services assets from Charles River Laboratories, a move designed to expand its early-stage research…
Read More...

Japanese industrial giant Asahi Kasei has agreed to acquire German biopharmaceutical firm Aicuris Anti-infective Cures AG for about €780 million (roughly $919 million), a deal aimed at…
Read More...

After a successful gathering in Amsterdam earlier this year, the SmartLab Exchange USA will be hosted in a new city for 2026, making its Philadelphia debut this April. The Exchange…
Read More...

NorthX Biologics and Demeetra have announced a strategic collaboration aimed at streamlining biologics development and accelerating biotech companies’ progress toward investigational…
Read More...

Slate Medicines, Inc. has emerged from stealth with $130 million in Series A financing and the in-licensing of a promising migraine therapy, positioning the company to compete in the…
Read More...

GSK plc announced that ViiV Healthcare has reported positive 12-month interim results from its phase IIb EMBRACE study, highlighting the potential of an ultra long-acting HIV treatment…
Read More...

GSK plc has agreed to acquire 35Pharma Inc., a privately held Canadian biopharmaceutical company focused on protein-based therapeutics. The deal brings into GSK’s pipeline HS235, an…
Read More...

Gilead Sciences, Inc. has entered into a definitive agreement to acquire Arcellx in a transaction valued at approximately $7.8 billion, strengthening its oncology and cell therapy…
Read More...